Idelalisib Products | Cleanchem - Idelalisib is a phosphoinositide 3-kinase (PI3K) inhibitor used to treat certain types of blood cancers, such as chronic lymphocytic leukemia (CLL) and follicular lymphoma. By blocking PI3K, it inhibits the signaling pathways that promote cancer cell survival and proliferation, leading to cancer cell death. It is usually administered orally.

N-Nitroso Idelalisib

Cat. No: CL-IDL-NO-01

CAS No: NA

Mol. F: C22H17FN8O2

Mol. Wt: 444.43

Inv. Status: Custom Synthesis

N-Nitroso Idelalisib Impurity 1

Cat. No: CL-IDL-NO-02

CAS No: NA

Mol. F: C22H19FN8O3

Mol. Wt: 462.45

Inv. Status: Custom Synthesis

N-Nitroso Idelalisib Impurity 2

Cat. No: CL-IDL-NO-03

CAS No: NA

Mol. F: C22H18FN9O4

Mol. Wt: 491.44

Inv. Status: Custom Synthesis

N-Nitroso Idelalisib Impurity 3

Cat. No: CL-IDL-NO-04

CAS No: NA

Mol. F: C22H18N8O2

Mol. Wt: 426.44

Inv. Status: Custom Synthesis

N-Nitroso Idelalisib Impurity 4

Cat. No: CL-IDL-NO-05

CAS No: NA

Mol. F: C39H32FN11O3

Mol. Wt: 721.76

Inv. Status: Custom Synthesis

N-Nitroso Idelalisib Impurity 5

Cat. No: CL-IDL-NO-06

CAS No: NA

Mol. F: C39H32FN11O3

Mol. Wt: 721.76

Inv. Status: Custom Synthesis

N-Nitroso Idelalisib Impurity 6

Cat. No: CL-IDL-NO-07

CAS No: NA

Mol. F: C39H32FN11O3

Mol. Wt: 721.76

Inv. Status: Custom Synthesis

N-Nitroso Idelalisib Impurity 7

Cat. No: CL-IDL-NO-08

CAS No: NA

Mol. F: C22H17FN8O2

Mol. Wt: 444.43

Inv. Status: Custom Synthesis

N-Nitroso idelalisib Impurity 8

Cat. No: CL-IDL-NO-09

CAS No: NA

Mol. F: C22H17FN8O2

Mol. Wt: 444.43

Inv. Status: Custom Synthesis

N-Nitroso Idelalisib Impurity 9

Cat. No: CL-IDL-NO-10

CAS No: NA

Mol. F: C21H15FN8O2

Mol. Wt: 430.4

Inv. Status: Custom Synthesis

N-Nitroso Idelalisib Impurity 10

Cat. No: CL-IDL-NO-11

CAS No: NA

Mol. F: C21H15FN8O2

Mol. Wt: 430.4

Inv. Status: Custom Synthesis